The updated labeling was supported by modeling data and in vivo results from the Dose Optimization study (see graph) and the ...
(RTTNews) - MannKind Corporation (MNKD) announced that the U.S. FDA has approved an update to the Afrezza prescribing information, adding new guidance for determining the starting mealtime dose when ...
Following a more than two-fold rise in value last week, shares of ImmunityBio (IBRX) added ~16% in the premarket on Tuesday after the company announced updates from a meeting held with the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results